Our present study design aimed at the evaluation of the biological activity along with a computational study (DFT, molecular docking, ADME/T), where the MAO-A and serotonin receptor are used as a molecular targets for oxime derivatives in depression disorders. This evidence concerns the gene MAOA and depressive disorder.